Andorra vs Dominica: Tuberculosis patients living with HIV receiving antiretroviral therapy
Andorra
0 patients
in 2021
Dominica
0 patients
in 2021
Andorra rank
141st
Dominica rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Andorra
- Dominica
How they compare
Andorra currently reports 0 patients against 0 patients in Dominica, a difference of 0 patients.
Across all 14 years both countries report, Dominica has been ahead every year.
Andorra ranks 141st and Dominica ranks 141st of 183 countries.
Dominica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Dominica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0.6667 patients | 0.6667 patients | Dominica |
| 2010s | 0.1 patients | 0.3 patients | 0.2 patients | Dominica |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Andorra or Dominica?
- Andorra, at 0 patients against 0 patients in Dominica as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Andorra and Dominica?
- 0 patients, with Andorra ahead.
- How many years of comparable data are there for Andorra and Dominica?
- 14 years are reported by both, from 2007 to 2021.
- How do Andorra and Dominica rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Andorra ranks 141st and Dominica ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.